HomeMedical SpecialtiesNeurologyNew tool helps target brain tumours with pinpoint precision

New tool helps target brain tumours with pinpoint precision

Published on

By Monica Matys

Life took a turn for Andrew Stewart five years ago. First, a diagnosis of skin cancer. Then the cancer spread to three tumours in his brain.

“Just smaller than a grape, you know. And I think that’s quite large,” Andrew says of the tumours in his brain. “So my next worry was, if they are growing, are they going to press against to start giving me headaches?”

Andrew was referred to Sunnybrook, the first hospital in Canada to offer radiosurgery through a technology called the Gamma Knife Icon.

The Gamma Knife delivers focused radiation to tumours that have spread (metastasized) to a patient’s brain. The frameless Gamma Knife Icon means the patient doesn’t have to have a frame screwed into their head to keep them still while the radiation beams carefully target their brain tumours.

Patients lie on the device’s table, and are fitted with a customized mask to keep their head still during treatment. The customized Icon image-guidance system then allows for precise doses of radiation to be delivered to multiple tumours in the brain simultaneously.

This is a huge advance to delivering radiation, as opposed to whole brain radiation of the past, which can cause side effects like memory loss and fatigue. It also means patients skip the discomfort of having their head secured with screws in an invasive frame during treatment.

“For a long time, patients with brain tumours and metastases were largely considered at the end of life, and using the fanciest equipment known to man was thought to be unjustified,” says Dr. Arjun Sahgal, radiation oncologist and head of Sunnybrook’s Cancer Ablation Therapy program. “But as patients live longer, the focus is to make them live better, and using focused radiation can improve the ability for patients to maintain their memory and quality of life. We owe it to our patients to make their end of life as comfortable and as meaningful as we can, and to offer more patients radiosurgery that would have otherwise not have had access, and that’s why technology like the Gamma Knife Icon is so important.”

And for some patients, it can happen in less than one hour.

“My team and our patients used to stay late into the night in order to do treatments, and we were limited as to how many tumours we could treat due to technical difficulties and the time it took,” says Dr. Sahgal. “Now, we are able to treat patients with multiple metastases — 5, 10 or even 15 or more — with the Icon, and because it’s frameless we can break up the treatment into a few lesions a day instead of patients laying in the machine for 4 to 6 hours.”

Andrew says so far, he has had no side effects of radiosurgery, and was back to living a quality life right away.

Sunnybrook is now teaching other centres how to best use the Gamma Knife Icon, leading a North American Icon Research Group, and conducting research to push the potential of this technology even further ahead.

Life took a turn for Andrew Stewart five years ago. First, a diagnosis of skin cancer. Then the cancer spread to three tumours in his brain.

“Just smaller than a grape, you know. And I think that’s quite large,” Andrew says of the tumours in his brain. “So my next worry was, if they are growing, are they going to press against to start giving me headaches?”

Andrew was referred to Sunnybrook, the first hospital in Canada to offer radiosurgery through a technology called the Gamma Knife Icon.

The Gamma Knife delivers focused radiation to tumours that have spread (metastasized) to a patient’s brain. The frameless Gamma Knife Icon means the patient doesn’t have to have a frame screwed into their head to keep them still while the radiation beams carefully target their brain tumours.

Patients lie on the device’s table, and are fitted with a customized mask to keep their head still during treatment. The customized Icon image-guidance system then allows for precise doses of radiation to be delivered to multiple tumours in the brain simultaneously.

This is a huge advance to delivering radiation, as opposed to whole brain radiation of the past, which can cause side effects like memory loss and fatigue. It also means patients skip the discomfort of having their head secured with screws in an invasive frame during treatment.

“For a long time, patients with brain tumours and metastases were largely considered at the end of life, and using the fanciest equipment known to man was thought to be unjustified,” says Dr. Arjun Sahgal, radiation oncologist and head of Sunnybrook’s Cancer Ablation Therapy program. “But as patients live longer, the focus is to make them live better, and using focused radiation can improve the ability for patients to maintain their memory and quality of life. We owe it to our patients to make their end of life as comfortable and as meaningful as we can, and to offer more patients radiosurgery that would have otherwise not have had access, and that’s why technology like the Gamma Knife Icon is so important.”

And for some patients, it can happen in less than one hour.

“My team and our patients used to stay late into the night in order to do treatments, and we were limited as to how many tumours we could treat due to technical difficulties and the time it took,” says Dr. Sahgal. “Now, we are able to treat patients with multiple metastases — 5, 10 or even 15 or more — with the Icon, and because it’s frameless we can break up the treatment into a few lesions a day instead of patients laying in the machine for 4 to 6 hours.”

Andrew says so far, he has had no side effects of radiosurgery, and was back to living a quality life right away.

Sunnybrook is now teaching other centres how to best use the Gamma Knife Icon, leading a North American Icon Research Group, and conducting research to push the potential of this technology even further ahead.

 Monica Matys works in communications at Sunnybrook Health Sciences Centre.

Latest articles

New approach opens door to better-targeted treatments and faster drug discovery for complex diseases

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single-cell data with patient outcomes, the tool can predict disease progression and simulate responses to potential drug targets, helping accelerate drug discovery and repurposing. While still in development, SIDISH shows promise for advancing personalized cancer care and improving outcomes across multiple tumour types.

Canadian Cancer Society urges lowering colorectal cancer screening age to 45

The Canadian Cancer Society is urging provinces to lower the colorectal cancer screening age from 50 to 45, citing rising rates among younger adults and evidence that earlier screening could prevent over 15,000 cases and 6,100 deaths. Younger patients are more often diagnosed at advanced stages, making early detection critical. Expanding access to simple screening tools like FIT tests could significantly improve outcomes and save lives.

Unleashing natural killer cells against cancer

Researchers at McGill University have developed a new strategy to enhance natural killer (NK) cells, enabling them to better penetrate tumour defenses and destroy cancer cells. Using small-molecule drugs to temporarily boost NK cell activity—rather than permanent genetic modification—the approach showed strong results against multiple hard-to-treat cancers in preclinical studies. The scalable, ready-to-use therapy could make immunotherapy faster, safer, and more accessible, with future clinical trials planned for aggressive cancers like acute myeloid leukemia.

Doctors report false health information, lack of health data sharing put patient care at risk

A new CMA survey reveals major risks to patient care in Canada, with 99% of physicians reporting that disconnected health systems limit access to critical patient information and nearly half witnessing serious adverse outcomes as a result. At the same time, 97% of doctors say they have intervened to address harm caused by false or misleading online health information, including AI-generated advice. The findings highlight the urgent need for integrated digital health systems and stronger efforts to promote reliable health information.

More like this

Martha Tripicio – Nursing Hero

Humber River Health t is with profound respect and admiration that I nominate Martha Tripicio...

Catherine Bergman – Nursing Hero

University Health Network Catherine Bergman is recognized at Toronto General Hospital for her clinical expertise,...

Iryna Fedoryak – Nursing Hero

Sunnybrook Health Sciences Centre (St. John’s Rehab) We are honoured to nominate Iryna Fedoryak for...

Domino Puson – Nursing Hero

Trillium Health Partners We are honoured to nominate Domino Puson for the 21st Annual Hospital...

Susan Davidson 3rd Place Nursing Hero

Unity Health (St. Joseph’s Health Centre) am honored to nominate Susan Davidson for the Nursing...

Rodolfo D. Lastimosa Jr. 2nd Place Nursing Hero

Southbridge Care Homes am honored to nominate Rodolfo D. Lastimosa Jr. for the Nursing Hero...